CITANEST PLAIN DENTAL Drug Patent Profile
Which patents cover Citanest Plain Dental, and what generic alternatives are available?
Citanest Plain Dental is a drug marketed by Dentsply Pharm and is included in one NDA.
The generic ingredient in CITANEST PLAIN DENTAL is prilocaine hydrochloride. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the prilocaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Citanest Plain Dental
A generic version of CITANEST PLAIN DENTAL was approved as prilocaine hydrochloride by SEPTODONT INC on September 29th, 2010.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CITANEST PLAIN DENTAL?
- What are the global sales for CITANEST PLAIN DENTAL?
- What is Average Wholesale Price for CITANEST PLAIN DENTAL?
Summary for CITANEST PLAIN DENTAL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 101 |
| Patent Applications: | 303 |
| DailyMed Link: | CITANEST PLAIN DENTAL at DailyMed |
US Patents and Regulatory Information for CITANEST PLAIN DENTAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dentsply Pharm | CITANEST PLAIN DENTAL | prilocaine hydrochloride | INJECTABLE;INJECTION | 021382-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
